Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis
- PMID: 7543781
- PMCID: PMC7101795
- DOI: 10.1007/BF00311527
Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis
Abstract
In this study, the ability of granulocyte colony-stimulating factor (G-CSF) to treat or prevent chemotherapy-induced oral mucositis in patients with advanced breast cancer was evaluated. A total of 14 patients who received intraarterial (i.a.) adriamycin (ADM) preoperatively were divided into two groups according to whether or not G-CSF was given. Thus, group A (n = 7) was given G-CSF and group B (n = 7) was not. G-CSF therapy reduced both the incidence and duration of ADM-induced oral mucositis, and a positive correlation was also seen between the incidence of mucositis and ADM-induced leukopenia (< 2,000/mm3). Group A was further divided into two subgroups according to whether G-CSF was given after or before the leukopenia had dropped below 2,000/mm3: group A-1 (n = 3) and group A-2 (n = 4), respectively. ADM-induced mucositis was observed in two of the three patients in group A-1, but in none of the four patients in group A-2. These results strongly support the idea that G-CSF can effectively treat and prevent ADM-induced oral mucositis.
Similar articles
-
The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients.Adv Clin Exp Med. 2017 May-Jun;26(3):409-413. doi: 10.17219/acem/61913. Adv Clin Exp Med. 2017. PMID: 28791814
-
Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.J Clin Oncol. 1995 Oct;13(10):2620-8. doi: 10.1200/JCO.1995.13.10.2620. J Clin Oncol. 1995. PMID: 7595716 Clinical Trial.
-
Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients.Med Oncol. 1997 Mar;14(1):47-51. doi: 10.1007/BF02990946. Med Oncol. 1997. PMID: 9232612 Clinical Trial.
-
Granulocyte macrophage-colony stimulating factor and oral mucositis.Ann Pharmacother. 2002 Mar;36(3):517-20. doi: 10.1345/aph.10311. Ann Pharmacother. 2002. PMID: 11895067 Review.
-
Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.J Dent Res. 2006 Aug;85(8):690-700. doi: 10.1177/154405910608500802. J Dent Res. 2006. PMID: 16861284 Review.
Cited by
-
The cancer patient with severe mucositis.Curr Rev Pain. 2000;4(3):197-202. doi: 10.1007/s11916-000-0079-2. Curr Rev Pain. 2000. PMID: 10998733 Review.
-
Interventions for preventing oral mucositis for patients with cancer receiving treatment.Cochrane Database Syst Rev. 2011 Apr 13;2011(4):CD000978. doi: 10.1002/14651858.CD000978.pub5. Cochrane Database Syst Rev. 2011. PMID: 21491378 Free PMC article.
-
Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients.J Family Community Med. 1998 Jan;5(1):37-43. J Family Community Med. 1998. PMID: 23008581 Free PMC article.
-
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.Support Care Cancer. 2013 Jan;21(1):343-55. doi: 10.1007/s00520-012-1594-5. Epub 2012 Sep 18. Support Care Cancer. 2013. PMID: 22987094
-
Impact of systemic dexamethasone dosage on docetaxel-induced oral mucositis in patients with breast cancer.Sci Rep. 2023 Jun 22;13(1):10169. doi: 10.1038/s41598-023-37285-9. Sci Rep. 2023. PMID: 37349388 Free PMC article.
References
-
- Samueles BL, Vogelzang NJ, Ruane M, Simon MA. Continuous venous infusion of doxorubicin in advanced sarcomas. Cancer Treat Rep. 1987;71:971–972. - PubMed
-
- Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK. Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol. 1989;7:1407–1418. - PubMed
-
- Hederson JC, Allegra JC, Woodcock T, Wolff S, Bryan S, Cartwright K, Dukart G, Henry D. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol. 1989;7:560–571. - PubMed
-
- Gabizon A, Peretz T, Sulkes A, Amselem S, Ben-Yosef R, Ben-Baruch N, Catane R, Biran S, Berenholz Y. Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol. 1989;25:1795–1803. - PubMed
-
- Hortobagyi GN, Frye D, Buzdar AU, Ewer MS, Fraschini G, Hug V, Ames F, Montague E, Carrasco CH, Mackay B, Benjamin RS. Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma. Cancer. 1989;63:37–45. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources